News Search Results
Aug 12, 2025, 18:51 ET REPL Stock News: Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Replimune Group, Inc. Class Action Lawsuit
between November 22, 2024 and July 21, 2025. Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.
More news about: Robbins LLP
Aug 12, 2025, 17:31 ET Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight
TILs, the complex and time-intensive production process. The competitive landscape is becoming increasingly dynamic, with numerous biotechnology firms and academic institutions entering the TIL space. Strategic partnerships, technology licensing, and mergers & acquisitions are
More news about: DelveInsight Business Research, LLP
Aug 12, 2025, 16:05 ET Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update
Aug. 12, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Aug 12, 2025, 16:05 ET INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
MEETING, Pa., Aug. 12, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Aug 12, 2025, 13:12 ET New Study Confirms LP815® Probiotic Reduces Canine Anxiety and Aggression
https://doi.org/10.3390/ani15152280 About Verb BioticsVerb Biotics is a B2B biotechnology company that delivers clinically validated microbiome ingredients to functional food, beverage, dietary supplement, and companion animal brands.
More news about: Verb Biotics
Aug 12, 2025, 11:09 ET Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction
diseases including diabetes, heart failure, and kidney disease management. Tevogen Bio Holdings Inc. (NASDAQ: TVGN) has evolved from a biotechnology company into a dual-platform enterprise expanding into artificial intelligence through Tevogen.AI while maintaining 74% insider ownership. The company
More news about: USA News Group
Aug 12, 2025, 11:00 ET Gameto's $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial
As birth rates decline and US IVF access falls further behind, Gameto recruits first Phase 3 patients for cutting-edge biotechnology to reignite reproductive health possibilities Company's $127 million in total funding represents one of
More news about: Gameto
Aug 12, 2025, 11:00 ET Mice Model Market worth US$2.74 billion in 2030 with 10.0% CAGR | MarketsandMarkets™
participants. The US is the primary revenue contributor due to the concentration of contract research organizations, academic research centers, and biotechnology firms. Companies such as Charles River Laboratories (US), The Jackson Laboratory (US), and Inotiv (US) operate large-scale breeding and research
More news about: MarketsandMarkets
Aug 12, 2025, 10:01 ET Hearing Aids Market worth US$14.42 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
Japan), Eargo Inc. (US), Starkey Laboratories, Inc. (US), WSAudiology (Denmark), Zhejiang Nurotron Biotechnology Co., Ltd. (China), and MED-EL Medical Electronics (Austria), among others.
More news about: MarketsandMarkets
Aug 12, 2025, 10:00 ET Jocasta Neuroscience Lands $35 Million Series A to Advance Longevity Protein Program for Managing Cognitive Impairment
A. Coulter Endowed Chair in Aging and Neurodegenerative Disease as well, a Cofounder of Jocasta Neurosciences Inc. It was then licensed to Unity Biotechnology, Inc., a publicly traded company based in San Francisco, in 2018. Unity developed Klotho protein for several years
More news about: Jocasta Neurosciences Inc.
Aug 12, 2025, 10:00 ET Former Pfizer Chief Scientific Officer joins MC Sciences as Independent Chairman
remains a globally respected leader in pharmaceutical R&D. About MC Sciences MC Sciences is an emerging biotechnology company developing first-in-class, best-in-category therapeutics that target mast cells across high-need disease indications. The company's scientific
More news about: MC Sciences UG
Aug 12, 2025, 09:16 ET Scout Named to 2025 Inc. 5000 List of Fastest-Growing Private Companies
deliver face-to-face, virtual, and hybrid clinical meeting planning, patient payment, and travel and logistics support for top pharmaceutical and biotechnology companies. Learn more about our legacy at
More news about: Scout
Aug 12, 2025, 09:00 ET Catalyst Clinical Research Named to the 2025 Inc. 5000 List
Catalyst Clinical Research, a contract research organization (CRO), provides highly customizable solutions to the global biopharmaceutical and biotechnology industries through two established, branded solutions:
More news about: Catalyst Clinical Research
Aug 12, 2025, 09:00 ET Rezo Therapeutics Appoints Derek Hicks as CEO
Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today announced that Derek Hicks
More news about: Rezo Therapeutics
Aug 12, 2025, 08:05 ET Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and Trademark Office (USPTO) has issued
More news about: Anixa Biosciences, Inc.
Aug 12, 2025, 08:00 ET Diakonos Oncology Expands Leadership Team with Appointment of Donna Rill as Chief Technology Officer
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the appointment of Donna
More news about: Diakonos Oncology
Aug 12, 2025, 08:00 ET Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Aug 12, 2025, 08:00 ET Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update
Aug. 12, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, provides a
More news about: Coya Therapeutics, Inc.
Aug 12, 2025, 08:00 ET 180 Life Sciences (ETHZilla) Holds 82,186 ETH
top-tier DeFi founders, infrastructure pioneers and other ecosystem heavyweights. The Company, originally formed as an innovative biotechnology company, has also been evolving its business towards software enabled gaming and entertainment. In addition to its newly disclosed ETH
More news about: 180 Life Sciences Corp.
Aug 12, 2025, 07:47 ET Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
Aug. 12, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system
More news about: Intensity Therapeutics Inc.
Aug 12, 2025, 07:00 ET Apriori Bio Announces Collaboration with the Francis Crick Institute
CAMBRIDGE, Mass., Aug. 12, 2025 /PRNewswire/ -- Apriori Bio, a biotechnology company focused on developing variant-resilient vaccines, today announced a research collaboration with the Francis Crick Institute to better understand
More news about: Apriori Bio
Aug 12, 2025, 06:00 ET Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology
biotech renowned for its transformative technologies in adeno-associated viruses (AAV) manufacturing and tissue-targeted delivery. KLOTHO is a biotechnology company focused on the development of groundbreaking, disease-modifying cell and gene therapies using a human gene and protein derived from its
More news about: Klotho Neurosciences, Inc.
Aug 11, 2025, 21:36 ET Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million
March 2024. It is a biotechnology company specializing in the research and development of innovative therapies for autoimmune diseases with a core management team of experienced professionals with deep expertise in multinational pharmaceutical and biotechnology companies R&D, business development
More news about: Fosun Pharma
Aug 11, 2025, 16:55 ET Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
matters voted on at the annual meeting will also be filed on SEDAR. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in multiple first-line
More news about: Oncolytics Biotech® Inc.
Aug 11, 2025, 15:22 ET Aquaporin lowers revenue guidance for 2025, but maintains EBITDA guidance, and initiates strategic review
Aquaporin A/S (ticker: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces, pursuant to the Market Abuse Regulation on publication of inside information, that the Company is lowering its revenue guidance
More news about: Aquaporin A/S